The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

9 Mar 2022 07:00

RNS Number : 1042E
Electrocomponents PLC
09 March 2022
 

9 March 2022, 7.00am

 

Electrocomponents plc today issues a trading update for the nine weeks to 4 March 2022 and financial year to date

 

TRADING PERFORMANCE IS AHEAD OF EXPECTATIONS

 

LINDSLEY RUTH, CHIEF EXECUTIVE OFFICER, COMMENTED: "Despite a slightly slower start to the calendar year, our momentum has built leading to a strong performance over the last nine weeks. Consequently, our revenue and adjusted operating profit margin are tracking ahead of expectations. This has been achieved despite the challenging environment and toughening comparatives, a testament to the hard work and dedication of our people. Our continued investment in inventory has offset industry supply chain shortages while the strength of our model has enabled us to manage the challenges caused by the pandemic better than expected. Our strong solutions-led and omni-channel proposition is resonating with our customers and we are generating operating leverage to help offset rising costs. We are mindful of the increasing geopolitical uncertainties and, although we do not have operations in Ukraine or Russia, our thoughts are with everyone whose lives have been affected by these events. Despite these evolving external challenges, our ability to operate against headwinds and outperform our markets reinforces our confidence in our growth opportunities."

 

Like-for-like revenue growth(1)

Region

Q1 toJun 2021

Q2 toSep 2021

Q3 toDec 2021

9 weeks to4 Mar 2022

Year to date

EMEA

37%

22%

14%

17%

21%

Americas

40%

35%

37%

32%

34%

Asia Pacific

31%

31%

25%

24%

28%

Group

37%

26%

21%

22%

25%

 

Trading over the nine weeks to 4 March 2022 has been strong, delivering further market share growth

· Like-for-like revenue growth of 22%, despite tougher comparatives.

· Overall Group revenue grew 23% as acquisitions added 1% and trading days 2% offset by foreign exchange.

· Our industrial product ranges, which are c. 75% of Group revenue, also grew like-for-like revenue by 22%.

· EMEA's growth reflects growing customer numbers, deeper product offer and stronger sales focus. Italy and Germany were the strongest performers. The latter is mainly due to our investment in product range and digital customer experience, with minimal benefit to date from our distribution centre expansion.

· Americas' strength reflects our investment over recent years which is leading to a higher digital share, greater product depth and availability and a stronger collaboration between our sales and marketing teams.

· Asia Pacific's sharper sales focus is driving strong share growth within the industrial components market.

· Our own-brand, RS PRO, grew like-for-like revenue by 14%, due to a regional mix effect.

· Web like-for-like revenue increased by 27%, with like-for-like digital participation of 64%.

 

We are delivering sustainable improvements in adjusted operating profit margin despite ongoing investment

· Slightly stronger than expected gross margin is resulting from tighter pricing and discount approach.

· Operating leverage on our growing average order value is offsetting inflationary cost pressures, especially in labour.

· Inventory investment helped manage supply constraints which remain challenging and show no signs of easing.

· We continue to invest in operational capabilities to support our future growth plans and remain committed to our ESG goals and related business opportunities.

 

Our full year profit performance (to 31 March 2022) is anticipated to be ahead of consensus2 estimates

We are actively monitoring the potential impact of the increasing economic and political uncertainties on our markets, which may increase trading volatility. However, given our progress year to date we expect our full year revenue and adjusted operating profit margin to be ahead of the top end of the current consensus range.

 

Investor Event

We will be hosting an Investor Event for analysts and investors during the afternoon of 30 March 2022, commencing at 1.30pm UK time at East Wintergarden, 43 Bank Street, Canary Wharf, London E14 5NX. There will also be a live webcast for attendees who wish to join the event virtually. Given today's trading statement we are unlikely to provide a trading update with the Investor Event. For more details about the event or to attend, please contact InvestorRelations@electrocomponents.com.

 

LEI: 549300KVXDURRKVWR37

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Tulchan Communications

020 7353 4200

 

Notes:

1. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions and the effects of changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2020/21 is converted at 2021/22 average exchange rates for the period.  

2. Consensus for the year ending 31 March 2022 is adjusted profit before tax of £285.0 million within a range of £275.4 million to £290.9 million (source: Electrocomponents.com/investors/analyst-coverage).

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2021 for euro and US dollar respectively were €1.121 and $1.308 respectively. Every 1 cent movement in the euro has a c. £1.5 million impact on annual adjusted profit before tax. Every 1 cent movement in the US dollar has a c. £0.4 million impact on annual adjusted profit before tax.  

4. We expect to see a positive impact of around £9 million on revenue from additional trading days in 2021/22 compared to 2020/21.  

 

 

Conference call details 

There will be a conference call for analysts and investors today at 8.00am GMT via an audio conference call. A replay of the conference call will be provided shortly after the event via the investor relations page of the Electrocomponents website: www.electrocomponents.com/investors  

 

Pre-registration link 

If possible, please pre-register for this call to join digitally (without an operator), via the following link: www.incommglobalevents.com/registration/client/10278/electrocomponents%E2%80%99-conference-call/

 

Conference call timing 

Date: Wednesday, 9 March 2022

Time: 8.00am GMT

 

Participant dial-in via operator 

United Kingdom (local): 020 3936 2999

All other locations: +44 20 3936 2999

Access code: 589175 - Participants will be greeted by an operator who will register their details.

 

Replay details

A recording will be available until Wednesday 16 March 2022

UK: 020 3936 3001

USA: 1 845 709 8569

All other locations: +44 20 3936 3001

Or access online: www.incommglobalevents.com/replay/7631/electrocomponents-conference-call/  

Access Code: 914897

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLAVLITIIF
Date   Source Headline
3rd May 20224:15 pmRNSChange of Name
3rd May 20229:00 amRNSTotal Voting Rights
21st Apr 202210:00 amRNSHolding(s) in Company
12th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:45 amRNSTotal Voting Rights
31st Mar 20223:30 pmRNSCompany Secretary Change
30th Mar 20227:00 amRNSInvestor Event 2022: Our Journey to Greatness
28th Mar 202212:10 pmRNSDirectorate Change
28th Mar 202210:00 amRNSAdditional Listing
9th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSTrading Statement
1st Mar 20223:00 pmRNSTotal Voting Rights
25th Feb 20223:00 pmRNSHolding(s) in Company
15th Feb 20225:30 pmRNSHolding(s) in Company
8th Feb 20223:46 pmRNSNotice of Investor Event and Trading Update
1st Feb 20225:10 pmRNSHolding(s) in Company
1st Feb 20222:00 pmRNSTotal Voting Rights
1st Feb 20221:49 pmRNSBlock listing Interim Review
31st Jan 20225:30 pmRNSHolding(s) in Company
27th Jan 20225:50 pmRNSHolding(s) in Company
11th Jan 20223:30 pmRNSDirector/PDMR Shareholding
11th Jan 20227:00 amRNSTrading Statement
10th Jan 20224:00 pmRNSHolding(s) in Company
4th Jan 202211:04 amRNSTotal Voting Rights
17th Dec 20215:00 pmRNSHolding(s) in Company
17th Dec 20212:00 pmRNSNotice of Trading Update
10th Dec 202111:00 amRNSCompany Secretary Change
9th Dec 20219:37 amRNSHolding(s) in Company
7th Dec 202110:25 amRNSHolding(s) in Company
1st Dec 202110:21 amRNSTotal Voting Rights
11th Nov 20213:01 pmRNSHolding(s) in Company
10th Nov 20213:50 pmRNSHolding(s) in Company
4th Nov 20217:01 amRNSGlobal 2030 ESG Action Plan: For A Better World
4th Nov 20217:00 amRNSHalf-year Report
1st Nov 202110:00 amRNSTotal Voting Rights
8th Oct 20217:00 amRNSTrading Statement
1st Oct 202110:00 amRNSTotal Voting Rights
20th Sep 20211:00 pmRNSNotice of Trading Update
13th Sep 20213:00 pmRNSDirector/PDMR Shareholding
9th Sep 202112:00 pmRNSDirector/PDMR Shareholding
1st Sep 20219:59 amRNSTotal Voting Rights
3rd Aug 202110:07 amRNSTotal Voting Rights
3rd Aug 202110:05 amRNSBlock listing Interim Review
27th Jul 20216:18 pmRNSDirector/PDMR Shareholding
26th Jul 20216:06 pmRNSHolding(s) in Company
16th Jul 20213:00 pmRNSHolding(s) in Company
15th Jul 20213:00 pmRNSResult of AGM
8th Jul 20217:00 amRNSTrading Statement
7th Jul 20214:00 pmRNSDirectorate Change
1st Jul 202111:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.